Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody

References

• Geetha D, Jefferson JA. ANCA-Associated Vasculitis: core Curriculum 2020. Am J Kidney Dis. 2020;75(1):124–137. doi:10.1053/j.ajkd.2019.04.031
   PubMed Web of Science ®Google Scholar
• Martín-Nares E, Zuñiga-Tamayo D, Hinojosa-Azaola A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin Rheumatol. 2019;38(1):97–106. doi:10.1007/s10067-018-4212-1
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM. Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine. 2002;69(2):177–180. doi:10.1016/s1297-319x(02)00367-6
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Sinico RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol. 2002;29(5):918–923.
   PubMed Web of Science ®Google Scholar
• Hashimoto H. Microscopic polyangiitis in systemic sclerosis. Int J Rheumatol. 2010;2010:148528. doi:10.1155/2010/148528
   PubMedGoogle Scholar
• Quéméneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine. 2013;92(1):1–9. doi:10.1097/MD.0b013e31827781fd
   PubMed Web of Science ®Google Scholar
• Moxey J, Huq M, Proudman S, et al. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Res Ther. 2019;21(1):57. doi:10.1186/s13075-019-1839-5
   PubMedGoogle Scholar
• Kamen DL, Wigley FM, Brown AN. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis. J Rheumatol. 2006;33(9):1886–1888.
   PubMed Web of Science ®Google Scholar
• Kant S, Shah AA, Hummers LK, Wigley FM, Geetha D. ANCA-associated vasculitis in scleroderma: a renal perspective. Clin Nephrol. 2018;90(6):413–418. doi:10.5414/CN109445
   PubMed Web of Science ®Google Scholar
• Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C. Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis. Arch Med Sci. 2020. doi:10.5114/aoms.2019.85172
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–1755. doi:10.1136/annrheumdis-2013-204424
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
   PubMed Web of Science ®Google Scholar
• Suppiah R, Robson JC, Grayson PC, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis Rheumatol. 2022;74(3):400–406. doi:10.1002/art.41983
   PubMed Web of Science ®Google Scholar
• Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2022;74(3):386–392. doi:10.1002/art.41982
   PubMed Web of Science ®Google Scholar
• Robson JC, Grayson PC, Ponte C, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2022;74(3):393–399. doi:10.1002/art.41986
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–192. doi:10.1002/art.1780370206
   PubMed Web of Science ®Google Scholar
• Janion M. The Classification Of Cardiac Diagnosis. JAMA. 1921;77(18):1414–1415. doi:10.1001/jama.1921.02630440034013
   Google Scholar
• Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1). doi:10.1183/13993003.01913-2018
   Web of Science ®Google Scholar
• Penn H, Howie AJ, Kingdon EJ, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM: Int J Med. 2007;100(8):485–494. doi:10.1093/qjmed/hcm052
   PubMed Web of Science ®Google Scholar
• Savarino E, Furnari M, de Bortoli N, et al. Gastrointestinal involvement in systemic sclerosis. La Presse Médicale. 2014;43(10, Part 2):e279–e291. doi:10.1016/j.lpm.2014.03.029
   PubMed Web of Science ®Google Scholar
• Domenica Cappellini M, Motta I. Anemia in Clinical Practice—Definition and Classification: does Hemoglobin Change With Aging? Semin hematol. 2015;52(4):261–269. doi:10.1053/j.seminhematol.2015.07.006
   PubMed Web of Science ®Google Scholar
• Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006;133(5):468–492. doi:10.1111/j.1365-2141.2006.06038.x
   PubMed Web of Science ®Google Scholar
• Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol. 2015;37(5):489–500. doi:10.1007/s00281-015-0505-5
   PubMed Web of Science ®Google Scholar
• Wigley FM. Vascular disease in scleroderma. Clin Rev Allergy Immunol. 2009;36(2–3):150–175. doi:10.1007/s12016-008-8106-x
   PubMed Web of Science ®Google Scholar
• Kao L, Weyand C. Vasculitis in systemic sclerosis. Int J Rheumatol. 2010;2010:385938. doi:10.1155/2010/385938
   PubMedGoogle Scholar
• Guchelaar NAD, Waling MM, Adhin AA, van Daele PLA, Schreurs MWJ, Rombach SM. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis. Autoimmunity Rev. 2021;20(1):102716. doi:10.1016/j.autrev.2020.102716
   PubMed Web of Science ®Google Scholar
• Falk RJ, Jennette JC. Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis. N Engl J Med. 1988;318(25):1651–1657. doi:10.1056/NEJM198806233182504
   PubMed Web of Science ®Google Scholar
• Jennette JC, Wilkman AS, Falk RJ. Diagnostic predictive value of ANCA serology. Kidney Int. 1998;53(3):796–798. doi:10.1038/ki.1998.36
   PubMed Web of Science ®Google Scholar
• Niles JL, Pan GL, Collins AB, et al. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol. 1991;2(1):27–36.
   PubMed Web of Science ®Google Scholar
• Clark KE. Review of systemic sclerosis and antineutrophil cytoplasmic antibody vasculitis overlap: using autoantibodies for a personalised medicine approach. J Scleroderma Relat Disord. 2023;8(1):7–13. doi:10.1177/23971983221126850
   PubMed Web of Science ®Google Scholar
• Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP. Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology. 2013;52(10):1824–1831. doi:10.1093/rheumatology/ket213
   PubMed Web of Science ®Google Scholar
• Liang KP, Michet CJ. ANCA-associated vasculitis in scleroderma: a case series of fourteen patients. Rheumatology Reports. 2011;3(1):e2–e2. doi:10.4081/rr.2011.e2
   Google Scholar
• Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66(7):940–944. doi:10.1136/ard.2006.066068
   PubMed Web of Science ®Google Scholar
• Arad U, Balbir-Gurman A, Doenyas-Barak K, Amit-Vazina M, Caspi D, Elkayam O. Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011;41(2):223–229. doi:10.1016/j.semarthrit.2010.11.001
   PubMed Web of Science ®Google Scholar